Skip to main content
Clinical Trials/NCT04103190
NCT04103190CompletedNot Applicable

Multiparametric Imaging for Analysis of MVNT (Multinodular and Vacuolating Neuronal Tumor)

Fondation Ophtalmologique Adolphe de Rothschild7 sites in 1 country71 target enrollmentStarted: December 10, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
71
Locations
7
Primary Endpoint
Description of a new radiological entity on Spectroscopy : the MVNT (Multinodular and Vacuolating Neuronal Tumor)

Study Overview

Brief Summary

Differential diagnoses of MVNT include DNT (dysembryoplastic neuroepithelial tumor), low-grade gliomas, cortical dysplasias or even hamartomas.

Detailed Description

Differential diagnoses of MVNT include DNT (dysembryoplastic neuroepithelial tumor), low-grade gliomas, cortical dysplasias or even hamartomas.

However, in order to avoid an invasive surgical procedure to remove the lesion, a certain diagnosis of its benignity is essential. The contribution of advanced techniques in MRI, such as spectroscopy in the characterization of these lesions, has not yet been studied today

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patient over 18 years old
  • •Suspicion of MVNT on an MRI: it is considered that it will be necessary at least the 2 major criteria associated with at least 1 minor criterion to enter the definition of suspicion of MVNT:
  • •Major criteria:
  • •Multinodular aspect in cluster
  • •High FLAIR hypersignal / T2
  • •Minor criteria:
  • •Absence of mass effect
  • •Hyposignal T1
  • •Center of the lesion in hypsignal FLAIR or T1 hypersignal
  • •Affiliate or beneficiary of a Social Security scheme
  • •Having received informed information about the study and consenting to participate in the study

Exclusion Criteria

  • •Patient benefiting from a legal protection measure
  • •Pregnant or lactating woman
  • •Contraindication to MRI

Outcomes

Primary Outcomes

Description of a new radiological entity on Spectroscopy : the MVNT (Multinodular and Vacuolating Neuronal Tumor)

Time Frame: 1 day

ratio of N-Acetylaspartate / Choline on Spectroscopy

Description of a new radiological entity on Spectroscopy : : the MVNT (Multinodular and Vacuolating Neuronal Tumor)

Time Frame: 1 day

area under curve of choline Spectroscopie

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Network
Responsible Party
Sponsor

Study Sites (7)

Loading locations...

Similar Trials